Evogene Ltd. (EVGN) investors lift beneficial stake to 19.35% of shares
Rhea-AI Filing Summary
Evogene Ltd. shareholders led by L.I.A. Pure Capital Ltd. and Invest Pro Shukai Hon Ltd. report increased ownership following open-market purchases of 533,088 American Depositary Shares (ADSs) by Pure Capital using working capital.
After these transactions, the reporting persons collectively report beneficial ownership of 3,057,488 Ordinary Share equivalents, representing 19.35% of Evogene’s outstanding share capital, based on 15,801,407 Ordinary Shares outstanding as of July 27, 2026. Pure Capital has sole dispositive power over 2,501,388 ADSs and 56,100 Ordinary Shares (about 16.19% of the company), while Invest Pro has sole dispositive power over 500,000 ADSs (about 3.16%). Voting power over 3,001,388 ADSs and 56,100 Ordinary Shares is shared under an oral voting agreement. Kfir Silberman and Ron Yair Peled may be deemed beneficial owners through their control of Pure Capital and Invest Pro, respectively, but each disclaims beneficial ownership beyond their pecuniary interest.
Positive
- None.
Negative
- None.
Insights
Analyzing...
Key Figures
Key Terms
beneficial owner financial
dispositive power financial
pecuniary interest financial
Schedule 13(d) regulatory
oral voting agreement financial
FAQ
What ownership change in Evogene (EVGN) does this Schedule 13D/A report?
How many additional Evogene (EVGN) ADSs did Pure Capital acquire and how were they funded?
What is Invest Pro Shukai Hon Ltd.’s stake in Evogene (EVGN) after this amendment?
Who are the individuals behind the reporting entities in this Evogene (EVGN) Schedule 13D/A?
AI-generated analysis. How Rhea-AI works. Not financial advice.